{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:56:19Z","timestamp":1791608179363,"version":"4.3.4"},"reference-count":49,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of VitreoRetinal Diseases"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Purpose: To review the available literature on the efficacy and safety of suprachoroidal triamcinolone acetonide for the treatment of chorioretinal diseases. Methods: The results of a literature review were analyzed. Results: This review included 17 clinical studies of triamcinolone acetonide administration (6, diabetic macular edema; 1, central retinal vein occlusion [RVO]; 2, branch RVO; 7, noninfectious uveitis; 1, cystoid macular edema after cataract surgery). Overall, suprachoroidal triamcinolone acetonide was shown to be effective in decreasing macular thickness and increasing visual acuity (VA) in cases of chorioretinal diseases. The most frequently reported adverse events were eye pain, cataract, and increased intraocular pressure. Conclusions: Except for 3 sufficiently powered trials of suprachoroidal triamcinolone acetonide for macular edema associated with noninfectious uveitis, most other studies were clinical trials with small samples. These studies found that suprachoroidal triamcinolone acetonide has a satisfactory safety and efficacy profile. Further research with sufficiently large samples is required to confirm the potential role of suprachoroidal triamcinolone acetonide in retinal diseases.<\/jats:p>","DOI":"10.1177\/24741264241275271","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T14:19:33Z","timestamp":1729174773000},"page":"699-708","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["Suprachoroidal Triamcinolone Acetonide Injection to Treat Macular Edema: A Review"],"prefix":"10.1177","volume":"8","author":[{"given":"Samra","family":"Rahman","sequence":"first","affiliation":[{"name":"Karachi Medical and Dental College, North Nazimabad, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Tayyab","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Aga Khan University Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A. Rehman","family":"Siddiqui","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Sciences, Aga Khan University Hospital, Karachi, Pakistan"},{"name":"The Eye Centre, South City Hospital, Karachi, Pakistan"},{"name":"Shahzad Eye Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"bibr1-24741264241275271","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9010041"},{"key":"bibr2-24741264241275271","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13070967"},{"key":"bibr3-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.07.009"},{"key":"bibr4-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2021.12.002"},{"key":"bibr5-24741264241275271","volume":"13","author":"Villegas VM","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"issue":"13","key":"bibr6-24741264241275271","first-page":"5259","volume":"55","author":"Edelhauser HF","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bibr7-24741264241275271","first-page":"459","volume":"38","author":"Muya L","year":"2022","journal-title":"J Ocul Pharmacol Ther"},{"key":"bibr8-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2021.1867532"},{"key":"bibr9-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14042"},{"key":"bibr10-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.1997.tb00245.x"},{"key":"bibr11-24741264241275271","doi-asserted-by":"publisher","DOI":"10.35119\/asjoo.v16i4.434"},{"key":"bibr12-24741264241275271","volume":"28","author":"Ciulla T","year":"2022","journal-title":"Am J Manag Care"},{"key":"bibr13-24741264241275271","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020288"},{"key":"bibr14-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-020-0809-0"},{"key":"bibr15-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.9.11.27"},{"key":"bibr16-24741264241275271","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S351853"},{"issue":"2","key":"bibr17-24741264241275271","first-page":"42","volume":"36","author":"Tayyab H","year":"2020","journal-title":"Pak J Med Sci"},{"key":"bibr18-24741264241275271","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S361636"},{"key":"bibr19-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.03.001"},{"key":"bibr20-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2016.03.008"},{"key":"bibr21-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2016.10.011"},{"key":"bibr22-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20377"},{"key":"bibr23-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.16-20679"},{"key":"bibr24-24741264241275271","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20180831-07"},{"key":"bibr25-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2017.11.020"},{"key":"bibr26-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1159\/000455264"},{"key":"bibr27-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2022.03.021"},{"key":"bibr28-24741264241275271","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S185274"},{"key":"bibr29-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00843-z"},{"key":"bibr30-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/989501"},{"key":"bibr31-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0706736"},{"key":"bibr32-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2018.03.008"},{"key":"bibr33-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2020.08.007"},{"key":"bibr34-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7947710"},{"key":"bibr35-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1177\/03000605221089807"},{"key":"bibr36-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2017.07.013"},{"key":"bibr37-24741264241275271","unstructured":"Suprachoroidal injection of triamcinolone acetonide with IVT aflibercept in subjects with macular edema following RVO (SAPPHIRE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02980874."},{"key":"bibr38-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1167\/tvst.5.6.14"},{"key":"bibr39-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002279"},{"key":"bibr40-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-318019"},{"key":"bibr41-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.01.006"},{"key":"bibr42-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1954199"},{"key":"bibr43-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14024"},{"issue":"8","key":"bibr44-24741264241275271","first-page":"1139","volume":"106","author":"Khurana RN","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"bibr45-24741264241275271","volume":"13","author":"Hanif J","year":"2021","journal-title":"Cureus"},{"key":"bibr46-24741264241275271","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1464_20"},{"key":"bibr47-24741264241275271","doi-asserted-by":"publisher","DOI":"10.1177\/11206721231200034"},{"key":"bibr48-24741264241275271","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1128811"},{"key":"bibr49-24741264241275271","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081140"}],"container-title":["Journal of VitreoRetinal Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241275271","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/24741264241275271","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/24741264241275271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:26:36Z","timestamp":1790695596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/24741264241275271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1177\/24741264241275271"],"URL":"https:\/\/doi.org\/10.1177\/24741264241275271","relation":{},"ISSN":["2474-1264","2474-1272"],"issn-type":[{"value":"2474-1264","type":"print"},{"value":"2474-1272","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]}}}